Botanix Pharmaceuticals Ltd has released a press release.
Botanix Conference Commercial Update
Filed with ASX ·
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Botanix Pharmaceuticals Limited on 6ix
Story so far
Earlier from Botanix Pharmaceuticals
- S&P DJI Announces March 2025 Quarterly Rebalance
- December 2024 Quarterly Activities Report and Appendix 4C
- First Sofdra Prescriptions as Commercialisation Ramps Up
- Botanix Pharmaceuticals: Releases Quarterly Reports
- September 2024 Quarterly Activities Report and Appendix 4C
Later from Botanix Pharmaceuticals
- Botanix $40 Million Capital Raising for Sofdra Rollout
- March 2025 Quarterly Activities Report and Appendix 4C
- Pause in trading
- Botanix Responds to US Pharmaceutical Pricing Announcement
- Response to ASX Price Query Letter
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals